Incredibly Effective Protection from Fukushima Nuclear Radiation

A special study conducted by Dr. Atsuo Yanagisawa, M.D., Ph.D., from the Japanese College of Intravenous Therapy (JCIT) took a group of men working on the Fukushima site and administered 25,000 mg (milligrams) or 25 grams of vitamin C as a pretreatment prior to half of the men entering the area. What you’re about to learn is that this measure of protection may be one of the best when dealing with nuclear radiation effects.

A Solution to Fukushima’s Nuclear Radiation Effects

After their hazardous work, thorough medical evaluations determined they were clear of DNA damage and precancerous indicators that would have otherwise occurred from the radiation. The untreated workers showed DNA damage and precancerous indicators, but they received a similar post treatment protocol for a couple of months and recovered completely.

The Japanese College’s work and findings were supressed because TEPCO, the firm that owns the Fukushima plant, the Japanese government, and Japanese media all have ignored them and their science based advice.

Their report was published in the States by a major orthomolecular (nutritional medicine) information center, Orhomolecular.org. The report covers the JCIT study with links to JCIT’s videos. Very few media outlets know of this report.

Mega-dose vitamin C administered by IV (intravenously) gets more vitamin C into the bloodstream directly than orally administered C. Unfortunately it is difficult to find someone who will do IV C in the USA, thanks to our Medical Mafia. If you can find someone near you, it can be a bit pricey per treatment.

But there is another solution that anyone can access with less cost, and it can be taken orally. Liposomal encapsulated C surpasses even IV C’s ability to penetrate your cells, where it is ultimately needed. So it takes considerably less liposomal encapsulated vitamin C to equal thousands of milligrams of IV C.
The Alan Smith Story

The poster guy for liposomal encapsulated vitamin C is New Zealand farmer, Alan Smith. After the hospital threatened to take him off life support while he was in a coma with double pneumonia and leukemia complications from a bout with the flu, Alan’s family pushed for mega-dose vitamin C administered intravenously.

The vitamin C was administered for a couple of days, but doctors refused to continue even after Alan showed signs of improving. After the family got an attorney involved, the hospital resumed with much lower doses, going from 50 grams daily to two grams daily.

After this happened, Alan’s family found out about a new vitamin C product called Lypo-Spheric. It is an orally consumed gel in packets that can be ordered online. The family brought packets into Alan’s hospital room after he could begin eating again. After six days of only six grams of the vitamin C, Alan walked out of the hospital.

Alan Smith’s story was presented in New Zealand TV’s version of "60 Minutes." In the last few minutes of that presentation, you’ll see a still of Alan with those packets in his hospital room. Oh yeah, a year later Alan had no trace of leukemia.
How Liposomal C Works and How You Can Make Your Own

So how did six grams of oral C daily do the job of 50 grams daily of IV C? Dr. Tom Levy, a prominent orthomolecular physician with years of experience administering vitamin C intravenously was shocked to discover Lypo-Spheric was obtaining the same clinical results as mega-dose IV C. Dr. Levy came to realize that the combination of vitamin C and essential phospholipids radically improved cellular bioavailability.

Tiny particles of vitamin C coated with phospholipids create molecules of vitamin C coated with a substance similar to the cell walls. Thus those coated vitamin C molecules can slip into the cells easily. Encapsulation also avoids diarrhea thresholds of normal oral C.

You can even make your own liposomal encapsulated vitamin C. The homemade version is estimated to get around 60% of its vitamin C content into your body’s cells rather than 90%, but it’s more economical.

There are two similar methods for making your own liposomal C: One here and the other here.

I have no financial connections with Lypo-Spheric.

Source> Activist Post

Tesla Motors Launches Revolutionary Supercharger Enabling Convenient Long Distance Driving

HAWTHORNE, CA--(Marketwire - Sep 24, 2012) - Tesla Motors ( NASDAQ : TSLA ) today unveiled its highly anticipated Supercharger network. Constructed in secret, Tesla revealed the locations of the first six Supercharger stations, which will allow the Model S to travel long distances with ultra fast charging throughout California, parts of Nevada and Arizona. 

The technology at the heart of the Supercharger was developed internally and leverages the economies of scale of existing charging technology already used by the Model S, enabling Tesla to create the Supercharger device at minimal cost. The electricity used by the Supercharger comes from a solar carport system provided by SolarCity, which results in almost zero marginal energy cost after installation. Combining these two factors, Tesla is able to provide Model S owners¹ free long distance travel indefinitely.

Each solar power system is designed to generate more energy from the sun over the course of a year than is consumed by Tesla vehicles using the Supercharger. This results in a slight net positive transfer of sunlight generated power back to the electricity grid. In addition to lowering the cost of electricity, this addresses a commonly held misunderstanding that charging an electric car simply pushes carbon emissions to the power plant. The Supercharger system will always generate more power from sunlight than Model S customers use for driving. By adding even a small solar system at their home, electric car owners can extend this same principle to local city driving too.

The six California locations unveiled today are just the beginning. By next year, we plan to install Superchargers in high traffic corridors across the continental United States, enabling fast, purely electric travel from Vancouver to San Diego, Miami to Montreal and Los Angeles to New York. Tesla will also begin installing Superchargers in Europe and Asia in the second half of 2013.

The Supercharger is substantially more powerful than any charging technology to date, providing almost 100 kilowatts of power to the Model S, with the potential to go as high as 120 kilowatts in the future. This can replenish three hours of driving at 60 mph in about half an hour, which is the convenience inflection point for travelers at a highway rest stop. Most people who begin a road trip at 9:00 a.m. would normally stop by noon to have lunch, refresh and pick up a coffee or soda for the road, all of which takes about 30 minutes.

"Tesla's Supercharger network is a game changer for electric vehicles, providing long distance travel that has a level of convenience equivalent to gasoline cars for all practical purposes. However, by making electric long distance travel at no cost, an impossibility for gasoline cars, Tesla is demonstrating just how fundamentally better electric transport can be," said Elon Musk, Tesla Motors co-founder and CEO. "We are giving Model S the ability to drive almost anywhere for free on pure sunlight."

About Model S
With the most energy-dense battery pack in the industry and best-in-class aerodynamics, Model S has the longest range of any production electric car in the world. Model S comes with three battery options to fit the unique needs of different drivers. The 85 kWh Model S has received a U.S. fuel economy rating of 89MPGe and an EPA rated range of 265 miles.

Model S is the first premium sedan designed from the ground up to take full advantage of electric vehicle architecture. A revolutionary powertrain sits under the floorboard of Model S, creating an ultra-low center of gravity. Paired with an aluminum body engineered for superior handling, Tesla has created a vehicle that raises the bar for performance and efficiency while meeting the highest standards for safety.

Without an internal combustion engine or transmission tunnel, the interior of Model S has more cargo space than any other sedan in its class and includes a second trunk under the hood. Model S seats five adults and two children in optional rear-facing child seats. Model S Performance models accelerate from 0 to 60 mph in under 4.4 seconds. The interior features a 17" in-dash touchscreen with internet capabilities, allowing for streaming radio, web browsing and navigation.

Customers can reserve a Model S at one of Tesla's retail stores or online.

About Tesla
Tesla's goal is to accelerate the world's transition to electric mobility. Palo Alto, California-based Tesla designs and manufactures EVs and EV power train components for partners such as Toyota and Daimler. Tesla has delivered more than 2,350 Roadsters to customers worldwide. Model S, the first premium sedan to be built from the ground up as an electric vehicle, began deliveries in June 2012.

Interested in keeping up with Tesla Motors?
For more information on Tesla Motors and its products, please visit: teslamotors.com
For more information for Tesla Motors investors, please visit: ir.teslamotors.com
For the latest information from Tesla Motors, including press releases and the Tesla blog, please visit: teslamotors.com/press

Forward-Looking Statements
Certain statements in this press release including statements regarding future Supercharger locations and capabilities are "forward-looking statements" that are subject to risks and uncertainties. These forward-looking statements are based on management's current expectations. Various important factors could cause actual results to differ materially, including the risks identified in our SEC filings. Tesla disclaims any obligation to update this information.

¹ Supercharging hardware is standard on Model S vehicles equipped with an 85 kWh battery and optional on Model S vehicles equipped with a 60 kWh battery.

Russia suspends import and use of American GM corn after study revealed cancer risk

• The European Food Safety Authority orders review in to the research, conducted at a French university
• Russia's decision could be followed by other nations
• Experts at the University of Caen conducted an experiment running for the full lives of rats - two years
• The findings found raised levels of breast cancer, liver and kidney damage
• The same trials also found minuscule amounts of a commonly used weedkiller, Roundup
  
• Both the GM corn and Roundup are the creation of US biotech company Monsanto

By Sean Poulter

Russia has suspended the import and use of an American GM corn following a study suggesting a link to breast cancer and organ damage.

Separately, the European Food Safety Authority(EFSA), has ordered its own review in to the research, which was conducted at a French university.

The decision by Russia could be followed by other nations in what would be a severe blow to the take-up of the controversial technology.

Cancer risk? A farmer shows two corncobs of genetically engineered corn by U.S. company Monsanto, right, and two normal corncobs from Germany, left

Historically, biotech companies have proved the safety of GM crops based on trials involving feeding rats for a period of 90 days.

However, experts at the University of Caen conducted an experiment running for the full lives of rats - two years.

The findings, which were peer reviewed by independent experts before being published in a respected scientific journal, found raised levels of breast cancer, liver and kidney damage.

 

More...

• Outrage as Pennsylvania high school marching band commemorates 1917 Russian Revolution at half time
• An emotional Gwyneth Paltrow backs 'Stand Up To Cancer' campaign after losing her father to the disease ten years ago

The same trials also found evidence that consumption of minuscule amounts of a commonly used weedkiller, Roundup, was associated with a raised risk of cancer.

Both the GM corn, which carries the name NK603, and Roundup are the creation of US biotech company Monsanto.

The decision by the Russians to suspend authorisation for the American GM corn threatens to trigger a transatlantic commercial and diplomatic row.

Contentious: A combine harvests corn in a field near Coy, Arkansas. The decision by the Russians to suspend authorisation for the American GM corn threatens to trigger a transatlantic commercial and diplomatic row

Russia’s consumer rights watchdog, Rospotrebnadzor, said today that it has suspended the import and use of the Monsanto GM corn.

Rospotrebnadzor said the country’s Institute of Nutrition has been asked to assess the validity of the study.

It has also contacted the European Commission’s Directorate General for Health & Consumers to ask for the EU’s position on the corn’s safety.

Consumer scepticism in the UK and Europe means GM corn is not on supermarket shelves here, however it is fed to farm animals, including hens, pigs and dairy cows.

Last week Monsanto said it did not think the French study would affect its license to export the NK603 to Europe but would wait to hear from EFSA.

The company said: ‘Based on our initial review, we do not believe the study presents information that would justify any change in EFSA’s views on the safety of genetically modified corn products or alter their approval status for genetically modified imports.’

The biotech industry and university researchers involved in GM research have mounted a major PR campaign over the last year to win over sceptical consumers.

In the past week, pro-GM scientists have been lining up to undermine the French experiments and criticise the way they were conducted.

However, a number of independent academics have praised the French team’s work, describing it as the most thorough and extensive feeding trials involving GM to date.

Mustafa Djamgoz, the Professor of Cancer Biology, at Imperial College, London, said the findings relating to eating GM corn were a ‘surprise’.

Prof Djamgoz, who describes himself as a neutral on GM, said: ‘The results are significant. The experiments are, more or less, the best of their kind to date.’

However, he said that it is now important to ensure they are repeated with more animals by independent laboratories to confirm the outcome.

‘We are not scaremongering here. More research, including a repetition of this particular study are warranted,’ he said.

The professor said it will take two to three years to get a definitive answer.